532742
Paushak share price & financials
- Price
- ₹460
- Market cap
- ₹1.8k Cr
- Sector
- Chemicals
What Paushak does
Paushak Limited, part of the Alembic Group, manufactures phosgene and phosgene-based specialty chemical intermediates and derivatives that serve as building blocks for pharmaceutical and agrochemical manufacturers. The company operates from a single manufacturing facility at Panelav, Taluka Halol, in Panchmahal district, Gujarat, where it is building a new multipurpose plant and an R&D complex to replace legacy production lines and add new derivative streams. It has no subsidiaries or joint ventures, functioning as a standalone specialty-chemicals manufacturer.
- Manufacturing facilities
- 1
- Manufacturing facility location
- Panelav, Taluka Halol, District Panchmahal, Gujarat
- Subsidiaries / joint ventures
- None — standalone operations
Quarterly results
Q1 FY27: revenue up 50.0%, net profit up 25.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 57 | 49 | 52 | 56 | 59 +4% | 49 +0% | 55 +6% | 84 +50% |
| EBITDA | 17 | 15 | 16 | 18 | 15 −12% | 11 −27% | 17 +6% | 26 +44% |
| Net profit | 14 | 15 | 10 | 12 | 9 −36% | 6 −60% | 13 +30% | 15 +25% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −87.9% 1Y
1Y: ₹6,033.9 on 10 Sept 2025 → ₹730. High ₹6,060.1 (11 Sept 2025), low ₹345.6 (30 Mar 2026).
Financials, as filed
Revenue grew 1.2% a year over 3 years, FY23 to FY26. Operating margin narrowed to 27.9%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹212 Cr | ₹207 Cr | ₹210 Cr | ₹219 Cr |
| Operating profit | ₹75 Cr | ₹64 Cr | ₹60 Cr | ₹61 Cr |
| Operating margin | 35.4% | 30.9% | 28.6% | 27.9% |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Depreciation | ₹13 Cr | ₹13 Cr | ₹16 Cr | ₹21 Cr |
| Net profit | ₹54 Cr | ₹54 Cr | ₹49 Cr | ₹40 Cr |
| Net margin | 25.6% | 26.1% | 23.3% | 18.3% |
| Cash from operations | ₹43 Cr | ₹56 Cr | ₹38 Cr | ₹54 Cr |
| Free cash flow | ₹28 Cr | ₹17 Cr | ₹-122 Cr | ₹-34 Cr |
| ROCE | 21.0% | 17.0% | 11.0% | 8.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹12 Cr |
| Reserves | ₹269 Cr | ₹302 Cr | ₹351 Cr | ₹405 Cr | ₹477 Cr | ₹479 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹60 Cr | ₹77 Cr |
| Other liabilities | ₹57 Cr | ₹61 Cr | ₹61 Cr | ₹73 Cr | ₹80 Cr | ₹92 Cr |
| Total liabilities | ₹329 Cr | ₹367 Cr | ₹415 Cr | ₹481 Cr | ₹620 Cr | ₹660 Cr |
| Fixed assets | ₹51 Cr | ₹147 Cr | ₹149 Cr | ₹152 Cr | ₹183 Cr | ₹377 Cr |
| Capital work in progress | ₹68 Cr | ₹8 Cr | ₹7 Cr | ₹29 Cr | ₹205 Cr | ₹26 Cr |
| Investments | ₹154 Cr | ₹151 Cr | ₹182 Cr | ₹223 Cr | ₹131 Cr | ₹150 Cr |
| Other assets | ₹56 Cr | ₹61 Cr | ₹78 Cr | ₹77 Cr | ₹100 Cr | ₹107 Cr |
| Total assets | ₹329 Cr | ₹367 Cr | ₹415 Cr | ₹481 Cr | ₹620 Cr | ₹660 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, DIIs trimmed −0.47 pp while the public added +0.32 pp. The shareholder count grew 6% to 21,399.
- Promoters
- 67.3%
- DIIs
- 0.1%
- Public
- 32.7%
Since Jun 2025
- DIIs −0.47 pp
- Public +0.32 pp
- Promoters +0.14 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 67.0%, FIIs 0.0%, Public 33.0%.Dec '23: Promoters 67.0%, FIIs 0.0%, DIIs 0.1%, Public 32.9%.Mar '24: Promoters 67.0%, FIIs 0.0%, DIIs 0.2%, Public 32.8%.Jun '24: Promoters 67.0%, DIIs 0.3%, Public 32.7%.Sep '24: Promoters 67.0%, DIIs 0.3%, Public 32.7%.Dec '24: Promoters 67.0%, DIIs 0.4%, Public 32.6%.Mar '25: Promoters 67.1%, FIIs 0.0%, DIIs 0.5%, Public 32.3%.Jun '25: Promoters 67.1%, DIIs 0.5%, Public 32.3%.Sep '25: Promoters 67.3%, DIIs 0.7%, Public 32.0%.Dec '25: Promoters 67.3%, DIIs 0.7%, Public 32.0%.Mar '26: Promoters 67.3%, DIIs 0.3%, Public 32.5%.Jun '26: Promoters 67.3%, DIIs 0.1%, Public 32.7%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Paushak above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Nirayu Private Limited | 41.15% | unchanged |
| Alembic Limited | 19.07% | unchanged |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | 4.09% | −0.17 pp |
| Chirayu Ramanbhai Amin | 2.91% | unchanged |
| Malika Chirayu Amin | 1.22% | unchanged |
| Pranav Chirayu Amin | 0.92% | unchanged |
| Udit Chirayu Amin | 0.84% | unchanged |
| Shaunak Chirayu Amin | 0.84% | unchanged |
| Chirayu Ramanbhai Amin HUF | 0.31% | unchanged |
| Virsad Family Trust (Pranav Chirayu Amin) | 0.01% | unchanged |
| Laburnum Family Trust (Chirayu Ramanbhai Amin) | 0.01% | unchanged |
| Inaaya Shaunak Amin | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
Growth trapTo justify its price of ₹730, this stock must grow earnings at 29% every year for 7 years. Our analysis caps realistic growth at ~-10%. At that growth it is worth ₹91 — downside of 88%.
- Growth the price implies
- 29.1% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -9.6% a year
- net profit, FY23–FY26 · EPS -10.1%
- The gap
- 0.4 pp
- -88% downside if it only repeats history
Learn to analyse Paushak
Guides on how to read this kind of business and the numbers that matter.